ENTITY
Gilead Sciences

Gilead Sciences (GILD US)

160
Analysis
Health Care • United States
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
more
•24 Dec 2025 09:19•Broker

[2026 Outlook] Pharma/BiotechIdentifying Leaders Within an Outperforming Sector

In 1H25, US policy uncertainty—i.e., potential drug tariffs, the most-favored-nation (MFN) pricing proposal, and Inflation Reduction Act (IRA) drug...

Logo
358 Views
Share
bearish•Cross Asset Strategy
•11 Feb 2025 10:08•Broker

Earnings Results & US Inflation (Wednesday)

Technically, the SET Index is expected to move sideways down, with the support at 1,262/1,252 points and the resistance at 1,282/1,290 points. The...

Logo
91 Views
Share
bullish•Cross Asset Strategy
•08 Aug 2024 10:36•Broker

Keep a Close Watch on US Employment Figures

Technically, the SET Index is expected to move sideways up, with the resistance at 1,296 and 1,304 points and the support at 1,281/1,274...

Logo
91 Views
Share
bullish•Amata VN
•06 Nov 2024 09:57•Broker

US Election and Composite/Services PMIs in Japan and the EU

Technically, the SET Index is expected to move in response to the US presidential election results, with an upward trend anticipated if Kamala...

Logo
85 Views
Share
x